Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2024NutrientsOpen Access

A Patented Dietary Supplement (Hydroxy-Methyl-Butyrate, Carnosine, Magnesium, Butyrate, Lactoferrin) Is a Promising Therapeutic Target for Age-Related Sarcopenia through the Regulation of Gut Permeability: A Randomized Controlled Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMariangela RondanelliUniversity of PaviaCGClara GasparriUniversity of PaviaACAlessandro CavioniUniversity of Pavia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rondanelli et al. (2024) studied this question.

synapsesocial.com/papers/68e6ca9bb6db643587649464https://doi.org/10.3390/nu16091369
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of Polyphenol-Rich Diet Combined with Leucine, Vitamin D3, and Magnesium Supplementation on Self-Reported Mobility and Health Perception in Adults at Risk of Sarcopenia: A 3-Months Quasi-Experimental Study2026 · 1 citations
  2. 2The Combined Use of Hydroxymethylbutyrate and Branched-Chain Amino Acids to Counteract Uremic Sarcopenia2026
  3. 3A Specialized Multinutrient Formula Attenuates High-Fat-Diet-Associated Muscle Dysfunction and Sarcopenic Obesity-Related Features in Adult Mice2026
  4. 4The Combination of Lactoferrin and Creatine Ameliorates Muscle Decay in a Sarcopenia Murine Model2024 · 5 citations
  5. 5P0816The effects of high-protein oral nutritional supplement containing HMB in active Crohn’s Patients complicated with sarcopenia: interim analysis of an open-label, randomized, controlled Pilot Study2026